Vitamin D and methicillin-resistant Staphylococcus aureus nasal carriage

Scandinavian Journal of Infectious Diseases

Volumn 42, Issue 6-7, 2010, Pages 455-460

  Matheson, Eric M ^a   Mainous III, Arch G ^a   Hueston, William J ^a   Diaz, Vanessa A ^a   Everett, Charles J ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; VITAMIN D;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; CHILD; DRUG USE; FEMALE; GENDER; HEALTH STATUS; HEALTH SURVEY; HOSPITALIZATION; HUMAN; INCOME; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; POVERTY; RACE; RISK ASSESSMENT; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; BLOOD; CHI SQUARE DISTRIBUTION; HETEROZYGOTE; INFANT; MICROBIOLOGY; MIDDLE AGED; NOSE CAVITY; PRESCHOOL CHILD; RISK FACTOR; STAPHYLOCOCCAL INFECTIONS; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGED; CARRIER STATE; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; LOGISTIC MODELS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; NASAL CAVITY; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 77953280545     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365541003602049     Document Type: Article

References (33)

1. Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis 2007; 13:1840-1846
2. Safdar N, Bradley EA. The risk of infection after nasal colonization with Staphylococcus aureus. Am J Med 2008;121: 310-315
3. Davis KA, Stewart JJ, Crouch HK, Florez CE, Hospenthal DR. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis 2004;39: 776-782
4. Miller M, Cook HA, Furuya EY, Bhat M, Lee MH, Vavagiakis P, et al. Staphylococcus aureus in the community: colonization versus infection. PLoS One 2009;4:e6708.
5. Begier EM, Frenette K, Barrett NL, Mshar P, Petit S, Boxrud DJ, et al. Connecticut Bioterrorism Field Epidemiology Response Team. A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns. Clin Infect Dis 2004;39:1446-1453
6. Kazakova SV, Hageman JC, Matava M, Srinivasan A, Phelan L, Garfinkel B, et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 2005;352:468-475
7. Baggett HC, Hennessy TW, Rudolph K, Bruden D, Reasonover A, Parkinson A, et al. Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis outbreak in rural Alaska. J Infect Dis 2004;189:1565-1573
8. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006;355:666-674
9. Hidron AI, Kourbatova EV, Halvosa JS, Terrell BJ, McDougal LK, Tenover FC, et al. Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage. Clin Infect Dis 2005;41:159-166
10. Lucet JC, Chevret S, Durand-Zaleski I, Chastang C, Regnier B. Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit: results of a multicenter study. Arch Intern Med 2003;163:81-88
11. Kuehnert MJ, Kruszon-Moran D, Hill HA, McQuillan G, McAllister SK, Fosheim G, et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis 2006;193:172-179
12. Wintergerst ES, Maggini S, Hornig DH. Contribution of selected vitamins and trace elements to immune function. Ann Nutr Metab 2007;51:301-323
13. Yang S, Smith C, Prahl JM, Luo X, DeLuca HF. Vitamin D deficiency suppresses cell-mediated immunity in vivo. Arch Biochem Biophys 1993;303:98-106.
14. Adams JS, Ren S, Liu PT, Chun RF, Lagishetty V, Gombart AF, et al. Vitamin D-directed rheostatic regulation of monocyte antibacterial responses. J Immunol 2009;182: 4289-4295
15. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006;311:1770-1773
16. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004;173:2909-2912
17. Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S, et al. Epidemic influenza and vitamin D. Epidemiol Infect 2006;134:1129-1140
18. Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009;169:626-632
19. Centers for Disease Control and Prevention(CDC); National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. Hyattsville, MD: US Department of Health and Human Services; http://www.ced. gov/nchs/nhanes questionnnaires.htm (accessed February 19, 2010).
20. Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009;169:626-632
21. Kumar J, Muntner P, Kaskel FJ, Hailpern SM, Melamed ML. Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001-2004. PEDIATRICS Vol. 124 No.3 September 2009. pp. e362-e370.
22. Centeres for Disease Control and Prevention. Documentation, Codebook, and Frequencies Vitamin D May 2009. http://www.cdc.gov/nchs/data/nhanes/nhanes 05 06/vid d.pdf (accessed February 19, 2010).
23. Hollis BW, Horst RL. The assessment of circulating 25(OH) D and 1,25(OH)2D: where we are and where we are going. J Steroid Biochem Mol Biol 2007;103:473-476
24. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004;80(6 Suppl): 1689S-96S.
25. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357: 266-281
26. US Census Bureau. How the Census Bureau measures poverty September 2009. http://www.census.gov/hhes/www/ poverty/povdef.html. (accessed February 19, 2010).
27. Cantorna MT, Zhu Y, Froicu M, Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 2004;80(6 Suppl):1717S-20S.
28. Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007;167:1730-1737
29. Zaiou M, Nizet V, Gallo RL. Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/ LL-37) prosequence. J Invest Dermatol 2003;120:810-816
30. Travis SM, Anderson NN, Forsyth WR, Espiritu C, Conway BD, Greenberg EP, et al. Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun 2000;68:2748-2755
31. Sigmundsdottir H, Pan J, Debes GF, Alt C, Habtezion A, Soler D, et al. DCs metabolize sunlight-induced vitamin D3 to 'program' cell attraction to the epidermal chemokine CCL27. Nat Immunol 2007;8:285-293
32. Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the third National Health and Nutrition Examination Survey. Arch Intern Med 2009;169:384-390
33. Turner J, Cho Y, Dinh NN, Waring AJ, Lehrer RI. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother 1998;42: 2206-2214